MedPath

DOPamine Hydrochloride

DOPamine HYDROCHLORIDE Rx only

Approved
Approval ID

b61fffd0-7bc8-09e2-e053-2995a90ae0e4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 30, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dopamine Hydrochloride

PRODUCT DETAILS

NDC Product Code71872-7066
Application NumberNDA018132
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateMay 30, 2023
Generic NameDopamine Hydrochloride

INGREDIENTS (4)

SODIUM METABISULFITEInactive
Quantity: 9 mg in 1 mL
Code: 4VON5FNS3C
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Quantity: 10 mg in 1 mL
Code: XF417D3PSL
Classification: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Quantity: 5 mg in 1 mL
Code: B22547B95K
Classification: IACT
DOPAMINE HYDROCHLORIDEActive
Quantity: 40 mg in 1 mL
Code: 7L3E358N9L
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DOPamine Hydrochloride - FDA Drug Approval Details